News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
602,807 Results
Type
Article (62342)
Company Profile (124)
Press Release (540341)
Section
Business (162314)
Career Advice (2846)
Deals (29846)
Drug Delivery (116)
Drug Development (70769)
Employer Resources (169)
FDA (15035)
Job Trends (14078)
News (287133)
Policy (30631)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
Academia (2907)
Academic (2)
Accelerated approval (5)
Adcomms (26)
Allergies (80)
Alliances (41934)
ALS (91)
Alzheimer's disease (1374)
Antibody-drug conjugate (ADC) (111)
Approvals (15018)
Artificial intelligence (243)
Autoimmune disease (21)
Automation (14)
Bankruptcy (297)
Best Places to Work (10789)
BIOSECURE Act (20)
Biosimilars (109)
Biotechnology (88)
Bladder cancer (61)
Brain cancer (29)
Breast cancer (243)
Cancer (1968)
Cardiovascular disease (179)
Career advice (2377)
Career pathing (31)
CAR-T (141)
Cell therapy (384)
Cervical cancer (18)
Clinical research (57280)
Collaboration (714)
Compensation (202)
Complete response letters (25)
COVID-19 (2664)
CRISPR (39)
C-suite (212)
Cystic fibrosis (86)
Data (1894)
Decentralized trials (2)
Denatured (16)
Depression (45)
Diabetes (253)
Diagnostics (6266)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (42)
Drug discovery (110)
Drug pricing (114)
Drug shortages (31)
Duchenne muscular dystrophy (84)
Earnings (57314)
Editorial (38)
Employer branding (17)
Employer resources (146)
Events (77948)
Executive appointments (640)
FDA (16080)
Featured Employer (28)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (656)
Gene editing (96)
Generative AI (22)
Gene therapy (293)
GLP-1 (756)
Government (4407)
Grass and pollen (4)
Guidances (48)
Healthcare (17235)
Huntington's disease (21)
IgA nephropathy (25)
Immunology and inflammation (118)
Indications (26)
Infectious disease (2803)
Inflammatory bowel disease (121)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (83)
Interviews (542)
IPO (14116)
IRA (45)
Job creations (3651)
Job search strategy (1999)
Kidney cancer (9)
Labor market (32)
Layoffs (512)
Leadership (19)
Legal (8154)
Liver cancer (63)
Lung cancer (293)
Lymphoma (136)
Machine learning (4)
Management (60)
Manufacturing (277)
MASH (62)
Medical device (12061)
Medtech (12065)
Mergers & acquisitions (16198)
Metabolic disorders (663)
Multiple sclerosis (71)
NASH (20)
Neurodegenerative disease (95)
Neuropsychiatric disorders (30)
Neuroscience (1882)
NextGen: Class of 2025 (6223)
Non-profit (4547)
Northern California (2056)
Now hiring (27)
Obesity (362)
Opinion (253)
Ovarian cancer (68)
Pain (86)
Pancreatic cancer (76)
Parkinson's disease (137)
Partnered (20)
Patents (208)
Patient recruitment (94)
Peanut (47)
People (51598)
Pharmaceutical (31)
Pharmacy benefit managers (20)
Phase I (17159)
Phase II (24974)
Phase III (19837)
Pipeline (1056)
Podcasts (77)
Policy (132)
Postmarket research (2432)
Preclinical (7175)
Press Release (69)
Prostate cancer (93)
Psychedelics (36)
Radiopharmaceuticals (218)
Rare diseases (355)
Real estate (5768)
Recruiting (63)
Regulatory (20007)
Reports (39)
Research institute (2438)
Resumes & cover letters (447)
Rett syndrome (4)
RNA editing (4)
RSV (43)
Schizophrenia (72)
Series A (107)
Series B (76)
Service/supplier (9)
Sickle cell disease (49)
Southern California (1747)
Special edition (17)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3441)
State (2)
Stomach cancer (14)
Supply chain (61)
Tariffs (13)
The Weekly (59)
United States (18253)
Vaccines (683)
Venture capitalists (36)
Webinars (12)
Weight loss (266)
Women's health (35)
Worklife (17)
Date
Today (46)
Last 7 days (576)
Last 30 days (2359)
Last 365 days (29828)
2025 (7435)
2024 (31398)
2023 (35426)
2022 (46089)
2021 (50065)
2020 (49005)
2019 (43325)
2018 (32971)
2017 (29995)
2016 (29068)
2015 (33259)
2014 (26068)
2013 (23949)
2012 (23861)
2011 (24196)
2010 (21607)
Location
Africa (898)
Alabama (44)
Alaska (5)
Arizona (147)
Arkansas (14)
Asia (36876)
Australia (6583)
California (4672)
Canada (1711)
China (435)
Colorado (229)
Connecticut (234)
Delaware (105)
Europe (84880)
Florida (750)
Georgia (181)
Idaho (53)
Illinois (489)
India (22)
Indiana (255)
Iowa (7)
Japan (139)
Kansas (88)
Kentucky (20)
Louisiana (11)
Maine (68)
Maryland (684)
Massachusetts (3222)
Michigan (199)
Minnesota (282)
Mississippi (2)
Missouri (76)
Montana (26)
Nebraska (23)
Nevada (55)
New Hampshire (63)
New Jersey (1474)
New Mexico (28)
New York (1423)
North Carolina (867)
North Dakota (8)
Northern California (2056)
Ohio (185)
Oklahoma (14)
Oregon (31)
Pennsylvania (1092)
Puerto Rico (8)
Rhode Island (25)
South America (1255)
South Carolina (17)
South Dakota (1)
Southern California (1747)
Tennessee (85)
Texas (728)
Utah (169)
Virginia (129)
Washington D.C. (52)
Washington State (465)
West Virginia (3)
Wisconsin (38)
602,807 Results for "la trobe university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Sparta Science Partnering with La Trobe University and Sheffield Hallam University to Study Sub-Concussive Brain Injury
Sparta Science, the enterprise leader in Movement Health Intelligence, announced it is partnering with researchers from La Trobe University and Sheffield Hallam University on a collaborative project looking into the effect of head impact exposure on brain health and movement adaptability.
February 16, 2023
·
2 min read
Press Releases
RESTEM to Participate in Jones Las Vegas Technology and Innovation Conference
April 2, 2025
·
1 min read
Press Releases
Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
April 1, 2025
·
3 min read
Press Releases
Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion
March 24, 2025
·
9 min read
Press Releases
Agilent Presents Solutions Innovation Research Awards to Institut National de la Recherche Scientifique and University of Southern California Scientists
November 7, 2024
·
4 min read
Business
Cumulus Oncology Appoints Catherine Lewis La Torre to its Board of Directors
Cumulus Oncology, Europe’s first oncology-focused biotech company creation factory, announces the appointment of Catherine Lewis La Torre to its Board of Directors.
June 10, 2024
·
3 min read
Press Releases
PharmAla Completes Shipment of LaNeo™ MDMA to the University of Washington
March 24, 2025
·
3 min read
Press Releases
Stephen R. La Neve joins Insight Medbotics’ Board of Directors
November 12, 2024
·
1 min read
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology agreed to start a research collaboration to create antigens for the next-generation vaccines to deliver innovative solutions to unmet medical need in infectious diseases.
April 18, 2024
·
2 min read
Press Releases
Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)
February 10, 2025
·
19 min read
1 of 60,281
Next
